Loading page
Loading page
Loading substance route
In comparison to other substituted amphetamines, 2-FMA is particularly free of side effects such as nausea, high blood pressure, anxiety and an uncomfortable offset. It is considered to be an extremely functional and effective psychoactive substance for performing general…
The physical effects of 2-FMA can be broken down into several components which progressively intensify proportional to dosage.
The cognitive effects of 2-FMA can be broken down into several components which progressively intensify proportional to dosage.
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Chronic use can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. Compulsive redosing is reported as a potential cognitive effect.
When addiction has developed, cravings and withdrawal effects may occur if a person suddenly stops their usage. The substance is primarily associated with psychological rather than physical dependence.
The exact toxic dosage is unknown. The toxicity and long-term health effects of recreational 2-FMA use have not been studied in any scientific context.
Elevated blood pressure, increased heart rate, abnormal heartbeat, and vasoconstriction are reported, particularly at doses above the heavy dosage range; infrequent use of common doses likely poses minimal cardiovascular risk for healthy individuals.
Vaporization of 2-FMA is reported to be highly unpleasant and potentially dangerous, as heat can break the carbon-fluoride bond, releasing toxic fluorine-containing products; this risk is specific to vaporization and does not apply to oral or insufflated routes.
Use of amphetamine-class compounds at high dosages for prolonged periods can potentially result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Anxiety and paranoia typically occur with overly high doses or after redosing and staying awake for extended periods. A review of amphetamine-induced psychosis found approximately 5-15% of users fail to recover completely, though antipsychotic medications effectively resolve symptoms of acute psychosis.
Seizure risk may increase at high doses, though this is not commonly reported at typical use levels.
2-FMA emerged on the online research chemical market in August 2007, appearing alongside other fluorinated amphetamines such as 2-FA and 4-FA. That same month, forensic analysis of capsules delivered to Royal Adelaide Hospital in Australia revealed the presence of 2-FMA. The capsules appeared to…
Controlled since 1996 as an analogue of methamphetamine under the Controlled Drugs and Substances Act. Manufacturing, possession, and distribution are prohibited.
As of December 2024, 2-FMA is not specifically listed in French drug schedules. Possession exists in a legal grey area, though this status could change.
Currently unscheduled, though it falls within a substance group that may be subject to prohibition under recently passed New Psychoactive Substances legislation.
Specifically named under Verzeichnis E of Swiss controlled substances regulations. Unauthorized possession and distribution are prohibited.
Classified as a narcotic substance since July 2019. Possession, distribution, and production are illegal under Ukrainian law.
Not specifically scheduled under the Controlled Substances Act. However, as a close structural analogue of methamphetamine, sale or possession with intent for human consumption could potentially be prosecuted under the Federal Analogue Act.
Designated a controlled substance in October 2015. Production, sale, and possession are prohibited under national drug control regulations.
Listed under Anlage I of the Betäubungsmittelgesetz (Narcotics Act, Schedule I) since December 13, 2014. Manufacturing, possession, import, export, purchase, sale, procurement, and dispensing without a license are illegal. Violations are punishable by fines or imprisonment up to five years.
Controlled as an amphetamine analogue under the Misuse of Drugs Act. Possession, supply, and manufacture carry criminal penalties.
Classified as a controlled drug. Possession, production, supply, and importation are prohibited under Turkish drug legislation.
Controlled under the amphetamine analogue clause of the Misuse of Drugs Act 1971. Class A substances carry the most severe penalties, including up to seven years imprisonment for possession and life imprisonment for supply.
15 sources cited
